🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
ZLN
$ZLNA.OL
🔒 EuropeZelluna ASA
AVG HISTORICAL GAP
+1.09%
MAX GAP RECORD
+6.73%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $ZLNA.OL
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$ZLNA.OL
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 05, 2026 Earnings Release 2026-11-05 (BEFORE OPEN) | 🔮 UPCOMING 🔒 |
| Aug 20, 2026 Earnings Release 2026-08-20 (AFTER CLOSE) |
-4.55%
|
| May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN) |
+6.73%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.6%
Bullish Gaps (1)
Bearish Gaps (1)
Neutral / Flat (0)
📖 Intelligence Summary
Zelluna ASA is a biotechnology company focused on developing innovative and cost-efficient therapies for advanced solid cancers. It develops “off-the-shelf” TCR-guided NK cell therapies (TCR-NK) to treat solid cancers, offering broad cancer detection and scalable treatment. The company is headquartered in Oslo, Norway.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗